STAAR Surgical Reports Record Second Quarter Results for Total Revenue, ICL Sales and ICL Units
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
STAAR Surgical (STAA) Tops Q2 EPS by 4c, Slight Beat on Revenues
July 31, 2019 5:33 PM EDTSTAAR Surgical (NASDAQ: STAA) reported Q2 EPS of $0.08, $0.04 better than the analyst estimate of $0.04. Revenue for the quarter came in at $39.7 million versus the consensus estimate of $39.13 million.
Second Quarter 2019 Overview
Net Sales of $39.7 Million (Up 17%) as Reported and $40.3 Million (Up 19%) Constant Currency from the Prior Year QuarterICL Sales of $34.4 Million (Up 26%) as Reported and $34.9 Million (Up 28%) Constant Currency from the Prior Year QuarterICL Units Up 34% from the Prior Year QuarterGross Margin at 75.4% Up 100 Basis Points from the Prior Year QuarterNet Income... More
